(Q48183094)

9 February 2018

http://europepmc.org/abstract/MED/28477227

title

A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors (English)

1 reference

9 February 2018

http://europepmc.org/abstract/MED/28477227

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

7

Charles Erlichman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

8

Julian Molina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

6

Matthew P Goetz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Rui Qin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ruth Lupu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Daniel Satele

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Matthew Eadens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

5 May 2017

1 reference

9 February 2018

http://europepmc.org/abstract/MED/28477227

published in

Cancer Chemotherapy and Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1221-1227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28477227%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00280-017-3322-9

9 June 2020

exact match

0 references

cites work

Integrins: bidirectional, allosteric signaling machines

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

VEGF-integrin interplay controls tumor growth and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

The CCN family of proteins: structure-function relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Expression and regulation of Cyr61 in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Cyr61 promotes breast tumorigenesis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9

Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3322-9